Crayola Antibacterial Hand Wipes Cloth
NDC Package 70108-310-01
Package Information
Crayola Antibacterial Hand Wipes (benzalkonium chloride) cloths is uses Decreases bacteria on skin. This formulation utilizes a cloth delivery system. Marketed by Ashtel Studios Inc., this product is identified by NDC 70108-310 and is authorized under FDA application 505G(a)(3).
Identification & Billing
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Medicated Pad
- RxCUI: 1038558 - benzalkonium chloride 1.3 MG/ML Medicated Pad
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Topical Cloth
- RxCUI: 1038558 - benzalkonium chloride 0.13 % Topical Swab
- RxCUI: 1038558 - benzalkonium chloride 0.13 GM per 100 GM Topical Pad
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70108 - Ashtel Studios Inc.
- 70108-310 - Crayola Antibacterial Hand Wipes
- 70108-310-01 - 20 PATCH in 1 CANISTER / .001638 g in 1 PATCH
- 70108-310 - Crayola Antibacterial Hand Wipes
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70108-310). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70108-310-01 identifies a specific commercial package of 20 patch in 1 canister / .001638 g in 1 patch of Crayola Antibacterial Hand Wipes, a human over the counter drug labeled by Ashtel Studios Inc.. This cloth is formulated for topical use and contains benzalkonium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ashtel Studios Inc. on March 01, 2026. The current certification is valid through December 31, 2027.
How is this Ashtel Studios Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70108031001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.